Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Toxins (Basel)
2018 Feb 28;103:. doi: 10.3390/toxins10030097.
Show Gene links
Show Anatomy links
Prorocentrolide-A from Cultured Prorocentrum lima Dinoflagellates Collected in Japan Blocks Sub-Types of Nicotinic Acetylcholine Receptors.
Amar M
,
Aráoz R
,
Iorga BI
,
Yasumoto T
,
Servent D
,
Molgó J
.
???displayArticle.abstract???
Prorocentrolides are members of the cyclic imine phycotoxins family. Their chemical structure includes a 26-membered carbo-macrocycle and a 28-membered macrocyclic lactone arranged around a hexahydroisoquinoline that incorporates the characteristic cyclic imine group. Six prorocentrolides are already known. However, their mode of action remains undetermined. The aim of the present work was to explore whether prorocentrolide A acts on nicotinic acetylcholine receptors (nAChRs), using competition-binding assays and electrophysiological techniques. Prorocentrolide-A displaced [125I]α-bungarotoxin binding to Torpedo membranes, expressing the muscle-type (α1₂β1γδ) nAChR, and in HEK-293 cells, expressing the chimeric chick neuronal α7-5HT₃ nAChR. Functional studies revealed that prorocentrolide-A had no agonist action on nAChRs, but inhibited ACh-induced currents in Xenopus oocytes that had incorporated the muscle-type α1₂β1γδ nAChR to their membranes, or that expressed the human α7 nAChR, as revealed by voltage-clamp recordings. Molecular docking calculations showed the absence of the characteristic hydrogen bond between the iminium group of prorocentrolide-A and the backbone carbonyl group of Trp147 in the receptor, explaining its weaker affinity as compared to all other cyclic imine toxins. In conclusion, this is the first study to show that prorocentrolide-A acts on both muscle and neuronal nAChRs, but with higher affinity on the muscle-type nAChR.
Figure 1. General chemical structure of prorocentrolides and analogues. The nature of substituents R1 to R8 (colored in red) is detailed in Table 1. The cyclic imine group is colored in orange.
Figure 2. Effect of prorocentrolide-A on the human α7 nAChR expressed in Xenopus oocytes. (A) Typical inward nicotinic currents evoked by ACh (350 μM) applied for 3 s and recorded at −60 mV holding membrane potential. The blue tracings above the current traces denote the perfusion of ACh. The red tracing (above the current trace) denotes the perfusion of 2.5 μM prorocentrolide-A. Note that no current was evoked by the perfusion of the prorocentrolide alone, which indicates that it has no direct agonist action on the α7-receptor, while when applied together with ACh (red and blue tracing, MIX, 3rd current trace from left) a block of the peak inward current was observed. The washout of the prorocentrolide from the medium by the fast perfusion system allowed a partial recovery of the ACh evoked current (4th and 5th current tracings) as compared to the control currents (first two tracings). (B) Concentration-dependent inhibition of ACh-elicited nicotinic currents by prorocentrolide-A in oocytes expressing the human α7 nAChR. Peak amplitudes of ACh-evoked currents (mean ± SEM), recorded at −60 mV in the presence of the prorocentrolide were normalized to control currents, and fitted to the Hill equation (nH = 0.93). The concentration of ACh used was the EC50 determined.
Figure 3. Prorocentrolide-A and α-cobratoxin displaced, in a concentration-dependent manner, the specific [125I]α–BTX binding to HEK-293 cells, expressing the chimeric chick neuronal α7-5HT3 nAChR (A) and to Torpedo membranes expressing the muscle-type α12β1γδ nAChR; and (B) each point in the curves represents the mean ± SEM of three different experiments performed in duplicate.
Figure 4. Docking conformations of prorocentrolide-A at the subunit interface of muscle-type (left) and neuronal α7 nAChR (right). Residues within 4 Å from the ligand are shown. Loop C is hidden for more clarity.
igure 5. LC-MS chromatogram of the sample used in the experiments here reported. Note the relative abundance of prorocentrolide-A. The small peak component revealed at 9.55 min corresponds to the 9,51-dihydroprorocentrolide.
Figure 5. LC-MS chromatogram of the sample used in the experiments here reported. Note the relative abundance of prorocentrolide-A. The small peak component revealed at 9.55 min corresponds to the 9,51-dihydroprorocentrolide.
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009, Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Antil,
Variability among the sites by which curaremimetic toxins bind to torpedo acetylcholine receptor, as revealed by identification of the functional residues of alpha-cobratoxin.
1999,
Pubmed
Araoz,
Total synthesis of pinnatoxins A and G and revision of the mode of action of pinnatoxin A.
2011,
Pubmed
,
Xenbase
Aráoz,
The Neurotoxic Effect of 13,19-Didesmethyl and 13-Desmethyl Spirolide C Phycotoxins Is Mainly Mediated by Nicotinic Rather Than Muscarinic Acetylcholine Receptors.
2015,
Pubmed
,
Xenbase
Bialojan,
Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.
1988,
Pubmed
Bourne,
Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism.
2010,
Pubmed
,
Xenbase
Bourne,
Marine Macrocyclic Imines, Pinnatoxins A and G: Structural Determinants and Functional Properties to Distinguish Neuronal α7 from Muscle α1(2)βγδ nAChRs.
2015,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Celie,
Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.
2004,
Pubmed
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
Corringer,
Nicotinic receptors at the amino acid level.
2000,
Pubmed
Couesnon,
The Dinoflagellate Toxin 20-Methyl Spirolide-G Potently Blocks Skeletal Muscle and Neuronal Nicotinic Acetylcholine Receptors.
2016,
Pubmed
,
Xenbase
Dawson,
Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins.
1999,
Pubmed
Dellisanti,
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.
2007,
Pubmed
Eiselé,
Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities.
1993,
Pubmed
,
Xenbase
Fessard,
Okadaic acid treatment induces DNA adduct formation in BHK21 C13 fibroblasts and HESV keratinocytes.
1996,
Pubmed
Fujiki,
Unique features of the okadaic acid activity class of tumor promoters.
1999,
Pubmed
Fujiki,
Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
1993,
Pubmed
Hansen,
Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica.
2004,
Pubmed
Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed
Hibbs,
Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.
2009,
Pubmed
Hill,
Serine-specific phosphorylation of nicotinic receptor associated 43K protein.
1991,
Pubmed
Hu,
Isolation and structure of prorocentrolide B, a fast-acting toxin from Prorocentrum maculosum.
1996,
Pubmed
Kharrat,
The marine phycotoxin gymnodimine targets muscular and neuronal nicotinic acetylcholine receptor subtypes with high affinity.
2008,
Pubmed
,
Xenbase
Le Hégarat,
Genotoxicity of the marine toxin okadaic acid, in human Caco-2 cells and in mice gut cells.
2006,
Pubmed
Lee,
The Mechanism of Diarrhetic Shellfish Poisoning Toxin Production in Prorocentrum spp.: Physiological and Molecular Perspectives.
2016,
Pubmed
Lu,
Prorocentin, a new polyketide from the marine dinoflagellate Prorocentrum lima.
2005,
Pubmed
McLachlan,
Effects of nitrogen concentration and cold temperature on DSP-toxin concentrations in the dinoflagellate Prorocentrum lima (Prorocentrales, Dinophyceae).
1994,
Pubmed
Miledi,
Microtransplantation of neurotransmitter receptors from cells to Xenopus oocyte membranes: new procedure for ion channel studies.
2006,
Pubmed
,
Xenbase
Molgó,
Cyclic imine toxins from dinoflagellates: a growing family of potent antagonists of the nicotinic acetylcholine receptors.
2017,
Pubmed
Murray,
Are prorocentroid dinoflagellates monophyletic? A study of 25 species based on nuclear and mitochondrial genes.
2009,
Pubmed
Nagahama,
SPECIES BOUNDARIES IN THE TOXIC DINOFLAGELLATE PROROCENTRUM LIMA (DINOPHYCEAE, PROROCENTRALES), BASED ON MORPHOLOGICAL AND PHYLOGENETIC CHARACTERS(1).
2011,
Pubmed
Nakagama,
Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid.
1997,
Pubmed
Nascimento,
Morphology and phylogeny of Prorocentrum caipirignum sp. nov. (Dinophyceae), a new tropical toxic benthic dinoflagellate.
2017,
Pubmed
Otero,
Cyclic imines: chemistry and mechanism of action: a review.
2011,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Rogers,
Evaluation of cytotoxicity and genotoxicity of okadaic acid, a non-phorbol ester type tumour promoter, in V79 Chinese hamster lung cells.
1994,
Pubmed
Sands,
Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes.
1993,
Pubmed
,
Xenbase
Servent,
Only snake curaremimetic toxins with a fifth disulfide bond have high affinity for the neuronal alpha7 nicotinic receptor.
1997,
Pubmed
Sixma,
Acetylcholine binding protein (AChBP): a secreted glial protein that provides a high-resolution model for the extracellular domain of pentameric ligand-gated ion channels.
2003,
Pubmed
Stivala,
Synthesis and biology of cyclic imine toxins, an emerging class of potent, globally distributed marine toxins.
2015,
Pubmed
Suganuma,
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
1988,
Pubmed
Takai,
Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship.
1992,
Pubmed
Trainer,
Diarrhetic shellfish toxins and other lipophilic toxins of human health concern in Washington State.
2013,
Pubmed
Valdiglesias,
Okadaic acid: more than a diarrheic toxin.
2013,
Pubmed
Webb,
Protein Structure Modeling with MODELLER.
2017,
Pubmed
Yang,
Limaol: A Polyketide from the Benthic Marine Dinoflagellate Prorocentrum lima.
2017,
Pubmed